Survey Study About Endoscopy During COVID-19 Pandemic for IBD Doctors

Inflammatory Bowel Diseases Clinical Trial

Official title:

Patterns of Endoscopy During COVID-19 Pandemic: a Global Survey of Interventional Inflammatory Bowel Disease Practice

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04970849
• Other study ID #: I2020001357
• Status: Completed
• Start date: July 15, 2021
• Est. completion date: July 15, 2021

Study information

• Verified date: April 2020
• Source: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Performance of diagnostic or therapeutic endoscopic procedures in inflammatory bowel disease (IBD) patients can be challenging during a viral pandemic; the main concerns being the safety and protection of patients and health care providers (HCP). The aim of this study is to identify endoscopic practice patterns and outcomes of IBD and coronavirus disease 19 (COVID-19) with a worldwide survey of HCP.

Description:

The 20-item survey questionnaire was sent to physician members of the American Society for Gastrointestinal Endoscopy Special Interest Group in Interventional IBD, Chinese IBD Society Endoscopy Interest Group, and the China Crohn's and Colitis Foundation. The data of the survey was collected and analyzed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: July 15, 2021
• Est. primary completion date: July 15, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Doctors who are involved in the endoscopic treatment of IBD patients;

2. The endoscopist reads and signs an informed consent online. -

Exclusion Criteria:

1. Doctors who are not involved in the endoscopic treatment of IBD patients

2. Doctors who need the help of an agent, a witness, or someone else who can not complete the questionnaire independently.

3. Other conditions that the researchers considered unsuitable for inclusion or influenced the participants'ability to complete the study.-

Related Conditions & MeSH terms

• Inflammatory Bowel Diseases
• Intestinal Diseases

Intervention

Other:
• observation
IBD doctors who perform the endoscopy perform the questionnaire

Locations

Country	Name	City	State
China	Second Affiliated Hospital Zhejiang University School of Medicine	Zhengzhou	Hangzhou

Sponsors (1)

Lead Sponsor	Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

References & Publications (1)

Mao R, Liang J, Shen J, Ghosh S, Zhu LR, Yang H, Wu KC, Chen MH; Chinese Society of IBD, Chinese Elite IBD Union; Chinese IBD Quality Care Evaluation Center Committee. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gast — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The influence of covid-19 pandemic on endoscopic practice by IBD endoscopist	The incidence of scheduled IBD endoscopies were postponed or cancelled due to the pandemic.	1 week
Secondary	The incidence of COVID19 in IBD patients who underwent endoscopy	The percentage of IBD patients who underwent endoscopy since the outbreak was tested positive for COVID 19	1 week